论文信息 - Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast Cancer - 字舞流文

Phosphorylated/Activated HER2 as a Marker of Clinical Resistance to Single Agent Taxane Chemotherapy for Metastatic Breast Cancer

C. Hudis | L. Norton | C. Moskowitz | D. Stern | K. Panageas | A. Seidman | D. Carter | S. Modi | M. DiGiovanna | C. V. Van Poznak | L. Tan | Zhao Lu